EP0756461B1 - Produits du tabac ou substances analogues contenant des substances naturelles a action antioxydante, et leur procede de production - Google Patents
Produits du tabac ou substances analogues contenant des substances naturelles a action antioxydante, et leur procede de production Download PDFInfo
- Publication number
- EP0756461B1 EP0756461B1 EP95917934A EP95917934A EP0756461B1 EP 0756461 B1 EP0756461 B1 EP 0756461B1 EP 95917934 A EP95917934 A EP 95917934A EP 95917934 A EP95917934 A EP 95917934A EP 0756461 B1 EP0756461 B1 EP 0756461B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tobacco
- smokable
- natural substances
- filter
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000005445 natural material Substances 0.000 title claims abstract description 42
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims abstract description 13
- 230000008569 process Effects 0.000 title claims abstract description 8
- 239000000126 substance Substances 0.000 title claims description 44
- 235000019505 tobacco product Nutrition 0.000 title description 21
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims abstract description 60
- 241000208125 Nicotiana Species 0.000 claims abstract description 57
- 239000000463 material Substances 0.000 claims abstract description 27
- 241000196324 Embryophyta Species 0.000 claims abstract description 19
- 230000002790 anti-mutagenic effect Effects 0.000 claims abstract description 11
- 229940088594 vitamin Drugs 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 9
- 235000013343 vitamin Nutrition 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- 239000002243 precursor Substances 0.000 claims abstract description 3
- 235000019504 cigarettes Nutrition 0.000 claims description 42
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 32
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims description 17
- 239000005770 Eugenol Substances 0.000 claims description 17
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims description 17
- 229960002217 eugenol Drugs 0.000 claims description 17
- 239000004848 polyfunctional curative Substances 0.000 claims description 14
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical compound CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 claims description 12
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 8
- 229920002301 cellulose acetate Polymers 0.000 claims description 8
- 230000000391 smoking effect Effects 0.000 claims description 8
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 7
- 235000017803 cinnamon Nutrition 0.000 claims description 7
- 229940073505 ethyl vanillin Drugs 0.000 claims description 6
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 4
- 150000001299 aldehydes Chemical class 0.000 claims description 4
- 229940087168 alpha tocopherol Drugs 0.000 claims description 4
- 229960003471 retinol Drugs 0.000 claims description 4
- 239000011607 retinol Substances 0.000 claims description 4
- 235000020944 retinol Nutrition 0.000 claims description 4
- 229960000984 tocofersolan Drugs 0.000 claims description 4
- 235000004835 α-tocopherol Nutrition 0.000 claims description 4
- 239000002076 α-tocopherol Substances 0.000 claims description 4
- 235000008499 Canella winterana Nutrition 0.000 claims description 3
- 244000080208 Canella winterana Species 0.000 claims description 3
- 229940017545 cinnamon bark Drugs 0.000 claims description 3
- 239000011888 foil Substances 0.000 claims description 3
- 244000178870 Lavandula angustifolia Species 0.000 claims description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 2
- 235000014749 Mentha crispa Nutrition 0.000 claims description 2
- 244000024873 Mentha crispa Species 0.000 claims description 2
- 244000246386 Mentha pulegium Species 0.000 claims description 2
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 2
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 2
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 2
- 240000008790 Musa x paradisiaca Species 0.000 claims description 2
- 235000015266 Plantago major Nutrition 0.000 claims description 2
- 244000292697 Polygonum aviculare Species 0.000 claims description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 claims description 2
- 235000010401 Prunus avium Nutrition 0.000 claims description 2
- 244000007021 Prunus avium Species 0.000 claims description 2
- 235000005805 Prunus cerasus Nutrition 0.000 claims description 2
- 244000207449 Prunus puddum Species 0.000 claims description 2
- 235000009226 Prunus puddum Nutrition 0.000 claims description 2
- 241000220317 Rosa Species 0.000 claims description 2
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 2
- 240000002657 Thymus vulgaris Species 0.000 claims description 2
- 240000000377 Tussilago farfara Species 0.000 claims description 2
- 235000004869 Tussilago farfara Nutrition 0.000 claims description 2
- 235000009108 Urtica dioica Nutrition 0.000 claims description 2
- 239000000853 adhesive Substances 0.000 claims description 2
- 230000001070 adhesive effect Effects 0.000 claims description 2
- 235000020230 cinnamon extract Nutrition 0.000 claims description 2
- 235000001050 hortel pimenta Nutrition 0.000 claims description 2
- 239000001102 lavandula vera Substances 0.000 claims description 2
- 235000018219 lavender Nutrition 0.000 claims description 2
- 235000001510 limonene Nutrition 0.000 claims description 2
- 229940087305 limonene Drugs 0.000 claims description 2
- 239000001585 thymus vulgaris Substances 0.000 claims description 2
- 240000004160 Capsicum annuum Species 0.000 claims 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 claims 1
- 241001456088 Hesperocnide Species 0.000 claims 1
- 240000004760 Pimpinella anisum Species 0.000 claims 1
- 235000012550 Pimpinella anisum Nutrition 0.000 claims 1
- 150000001298 alcohols Chemical class 0.000 abstract description 3
- 229930005346 hydroxycinnamic acid Natural products 0.000 abstract description 3
- DEDGUGJNLNLJSR-UHFFFAOYSA-N hydroxycinnamic acid group Chemical class OC(C(=O)O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 abstract description 3
- 235000010359 hydroxycinnamic acids Nutrition 0.000 abstract description 3
- 230000003247 decreasing effect Effects 0.000 abstract description 2
- 150000002989 phenols Chemical class 0.000 abstract description 2
- 238000004113 cell culture Methods 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 210000003527 eukaryotic cell Anatomy 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000000779 smoke Substances 0.000 description 45
- 239000000835 fiber Substances 0.000 description 18
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 17
- 230000003505 mutagenic effect Effects 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 12
- 238000012360 testing method Methods 0.000 description 11
- 238000010953 Ames test Methods 0.000 description 8
- 231100000039 Ames test Toxicity 0.000 description 8
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 239000003344 environmental pollutant Substances 0.000 description 8
- 231100000243 mutagenic effect Toxicity 0.000 description 8
- 231100000719 pollutant Toxicity 0.000 description 8
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 231100000219 mutagenic Toxicity 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 206010028400 Mutagenic effect Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 239000001087 glyceryl triacetate Substances 0.000 description 6
- 235000013773 glyceryl triacetate Nutrition 0.000 description 6
- 229930014626 natural product Natural products 0.000 description 6
- 229960002622 triacetin Drugs 0.000 description 6
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 5
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 5
- 244000223014 Syzygium aromaticum Species 0.000 description 5
- 238000007792 addition Methods 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 5
- 229940117916 cinnamic aldehyde Drugs 0.000 description 5
- 229920005610 lignin Polymers 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- OVOUKWFJRHALDD-UHFFFAOYSA-N 2-[2-(2-acetyloxyethoxy)ethoxy]ethyl acetate Chemical compound CC(=O)OCCOCCOCCOC(C)=O OVOUKWFJRHALDD-UHFFFAOYSA-N 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000003292 glue Substances 0.000 description 4
- 231100000299 mutagenicity Toxicity 0.000 description 4
- 230000007886 mutagenicity Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 244000061176 Nicotiana tabacum Species 0.000 description 3
- 229920001131 Pulp (paper) Polymers 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 229940079322 interferon Drugs 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- FXFYOPQLGGEACP-UHFFFAOYSA-N 6-methylcoumarin Chemical compound O1C(=O)C=CC2=CC(C)=CC=C21 FXFYOPQLGGEACP-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 2
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 2
- 229920002079 Ellagic acid Polymers 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 235000006990 Pimenta dioica Nutrition 0.000 description 2
- 240000008474 Pimenta dioica Species 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- -1 Zimtaldehyd Chemical compound 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000002592 antimutagenic agent Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000000711 cancerogenic effect Effects 0.000 description 2
- 231100000357 carcinogen Toxicity 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 230000001364 causal effect Effects 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000004132 ellagic acid Nutrition 0.000 description 2
- 229960002852 ellagic acid Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 2
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 2
- 150000004005 nitrosamines Chemical class 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229930195730 Aflatoxin Natural products 0.000 description 1
- XWIYFDMXXLINPU-UHFFFAOYSA-N Aflatoxin G Chemical compound O=C1OCCC2=C1C(=O)OC1=C2C(OC)=CC2=C1C1C=COC1O2 XWIYFDMXXLINPU-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- 235000009355 Dianthus caryophyllus Nutrition 0.000 description 1
- 240000006497 Dianthus caryophyllus Species 0.000 description 1
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000005409 aflatoxin Substances 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- HMKKIXGYKWDQSV-KAMYIIQDSA-N alpha-Amylcinnamaldehyde Chemical compound CCCCC\C(C=O)=C\C1=CC=CC=C1 HMKKIXGYKWDQSV-KAMYIIQDSA-N 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003005 anticarcinogenic agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002557 mineral fiber Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000008164 mustard oil Substances 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- 230000036438 mutation frequency Effects 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000008030 superplasticizer Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-N trans-4-coumaric acid Chemical class OC(=O)\C=C\C1=CC=C(O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000004222 uncontrolled growth Effects 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/301—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by aromatic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
Definitions
- the present invention relates to tobacco products or tobacco products Similar goods with known antioxidants acting natural products and / or nature-identical synthetic products provided and intended for smoking, and methods of making these products.
- the human organism is a natural basic burden exposed to toxic substances and is therefore with a variety of mutagenic and carcinogenic substances, some of them on your own metabolism be formed by himself.
- the body's defense system is particularly important, which are also influenced individually by the way of life can.
- the food intake in the body a number of chemical reactions, whereby mutagen and antimutagen acting substances are closely interrelated.
- tobacco products are both cigarettes, cigarillos and tobacco cartridges (so-called plug-in cigarettes) with or without a filter as well Fine cut and pipe tobacco made entirely or in part of tobacco and / or another smokable material, as well as tobacco products Similar tobacco products such as “Kretek” cigarettes with the addition of up to 50% by weight of smokable spices, or to understand pure, tobacco-free plant cigarettes.
- WPI KIKKOMAN CORP describes the use of a tobacco filter, on which ellagic acid is applied in an amount of 1 - 20mg. This is said to stimulate tobacco smoke reduced and mildness added to the tobacco smoke without the Change the taste and smell of the smoke.
- ellagic acid namely a strong blood coagulation activity and an antioxidant Effect; but it is very expensive, which is known to the expert is so that under no circumstances will he think of this in to use such a high concentration in smoking articles.
- WPI NAKAJIMA discloses that a cigarette has a substance add to remove the harmful substances from the smoke can.
- the substance mentioned there is a mixture of different Individual components, to which ascorbic acid and Vanillin belong without knowing more about these individual components Statements would have been made.
- the object of the present invention is therefore in Creation of another tobacco product containing additives which further reduces the potential risks of smoking be, as well as in the provision of a method for manufacturing such tobacco products.
- they are antioxidative acting natural products and / or nature-identical synthesis products the same in the tobacco product in combination of one or more antioxidant vitamins and one or more contain other natural products of plant origin, where their relative amounts based on the total weight in Dependency of the intended target component or components of a smokable tobacco product may vary.
- the natural substances can be found in the smoking tobacco including the common additives as well as in individual the main stream smoke accessible components of tobacco products such as filters, Wrapping papers, substrates, seam glue etc. in a known manner Be incorporated or upgraded in a way that is beneficial to both Manufacturer of the tobacco product as well as proportionately with it Suppliers can happen.
- the pure natural substances When the pure natural substances are added to tobacco, lies their preferred relative amount in the range of 0.1 per thousand to 25 wt .-%, with a content between 1 and 5 wt .-% particularly is preferred.
- the preferred amounts are 0.1 to 50 wt .-%, with amounts of 1 to 20 wt .-% particularly preferred are.
- the filter used can be a chamber filter, a Cellulose acetate filter or a cellulose tangled fiber filter or a multiple filter, preferably a double filter (each with or without filter ventilation), the double filter a higher strand-side draw resistance and a lower one mouth-side draw resistance and an overall filter efficiency of 80 - 99%. Filters from other sources can also be used known filter materials in combination with the antioxidative acting natural substances are used.
- the natural substances according to the invention are contained from the outset in non-tobacco-containing, predominantly plant-based, smokable materials that are added to the tobacco, or alternatively the smokable mixture consists exclusively of optionally different, coordinated, non-tobacco-containing, plant-based materials with or without plant-specific, natural substances according to the invention, then also apply the preferred amounts of 0.1 per mille to 25% by weight, based on the pure natural substances, as well as the particularly preferred amounts of use of 1.0 to 5% by weight, the intended use amount in all cases by adding the pure natural substances or the pure substances according to the invention can be added to the smokable mixture.
- the substances of the invention Production of a smokable mixture in a manner known per se be added to the leaf cut and / or the rib cut, optionally using known adhesives and binders.
- the substances can be used in film or Tape tobacco are incorporated, which is particularly the case with offers the use of solid, ground natural products.
- a new type of plant foil that does not contain tobacco be at least partially the natural substances according to the invention in the form of herbal ingredients from parts of the contains vegetable film material.
- smokable base material a mixture of lamina tobacco or a mixture of lamina tobacco and foil tobacco or a tobacco-free Mixture of plant material, which comes from coltsfoot, Peppermint, nettle, white plantain, spearmint, Lavender, thyme, sweet or sour cherry leaves, knotweed leaves, Derived from rose petals, allspice leaves or cinnamon bark.
- the smokable material is a Combination of tobacco blend and tobacco-free blend is.
- the substances according to the invention can be in liquid form the casing and / or flavorings are added, whereby can even replace them.
- the usual filter systems essentially consist of either a filter fiber tow made from cellulose acetate fibers or from each other matted cellulose fibers, which are a cellulose tangled fiber fleece surrender.
- the filter fiber tow is usually during the manufacture of the cigarette filter with one of the permissible Sprayed harder to cross-link the fibers and thus the filter to harden.
- These hardeners mostly consist of triacetin or Triethylene glycol diacetate (TEGDA) and can according to the invention for Part or all of the natural substances according to the invention in liquid form, if they dissolve in the hardener or even act as a hardener, such as eugenol.
- Natural substances like eugenol, or in common hardeners like TEGDA can in turn be other natural substances such as cinnamaldehyde, ethyl vanillin, but also ⁇ -tocopherol, tocopherol acetate, Tocopherol succinate, retinol and retinol palmitate be solved so that bi- or ternary or multiple Mixtures of solutions result, which advantageously both as hardeners for cellulose acetate fibers as well as casing materials for smokable mixtures can be used.
- Suspensions of solid natural substances can also be used in the hardener, but also scattering of ground natural substances in filter fiber tow from cellulose acetate fibers.
- Flavoring Eugenol The different solubilities and miscibilities of some Flavorings and vitamins preferred according to the invention in or with the usual hardener substances triacetin and TEGDA as well as the natural usable according to the invention even as a hardening substance Flavoring Eugenol are shown in Table 2. From the Data in Table 2 are in particular the excellent solubilizers Properties of the hardener according to the invention or hardener component of usable eugenols. The However, substance eugenol can also be in the form of a mixture with others in Tables 2 and 3 as hardeners or solvents listed substances are used, the concrete Mixtures and their respective proportions taking into account their properties and their market prices as well as depending of the component or components to be treated of the invention Product can be easily selected.
- Particularly preferred is a mixture of 80 parts triacetin, 15 parts eugenol and 5 parts of ⁇ -tocopherol acetate.
- the in this ratio mixed substances result in a clear solution from which after abandonment on cellulose acetate fibers preferred triacetin and Diffuse eugenol into the interior of the fibers, creating the ⁇ -tocopherol acetate enriched on the surface of the filter fibers , and therefore particularly easy from here as an emitter acting "filter" can be transferred into the main stream smoke can.
- the filter to be used in the process for producing a tobacco product does not consist of cellulose acetate fibers, it and / or the other components of the later product, such as the smokable tobacco-containing or tobacco-free vegetable material, the cigarette paper and the suture to be used, are mixed according to the invention with a solution of the inventive ones Flavorings and vitamins (or provitamins) are treated, whereby individual representatives of these groups of substances can in turn be used as solvents.
- the respective solubilities and miscibilities of the entire substances in or with some of the natural substances which can also be used as solvents according to the invention are shown in Table 3.
- the inventive Substances already on the part of the filter material manufacturer be worked into the fleece.
- the solid substances according to the invention can, for example, in granular shape with a grain diameter of about 0.8 mm on the part of the filter rod manufacturer introduced into the chambers of chamber filters liquid substances according to the invention, taken up, for example, from wood flour or lignin granules, lignin which is particularly suitable or has a lot of antioxidant activity containing wood particles in fiber-dust or granulate form also solitary as chamber embedding materials or as self-supporting, porous or smoke-permeable press hinge in the desired Filter format can be used. Furthermore, also that which comes into contact with the main stream smoke when smoking Inside of the filter wrapping paper with the inventive Natural substances can be coated.
- the cigarette paper can with the natural substances according to the invention in encapsulated or unencapsulated form in a manner known per se Be provided in this way, both single and two-layer Cigarette papers are suitable.
- the inner tobacco rod wrapper which also mesh-like or highly porous (10 - 20,000 CORESTA) can be provided with the substances according to the invention.
- This net-like inner tobacco rod wrapping can predominantly or for Entirely made of a suitable antioxidant containing lignin Wood pulp are made, at least partially the fiber content of otherwise customary cigarette papers made from suitable unbleached lignin wood pulp.
- the test principle essentially consists in the fact that histidine auxotrophic (his - ) indicator bacteria of the species Salmonella typhimurium mutate back into their prototrophic form (his + ) under the influence of mutagenic substances. Carrying out the Ames test, with or without “S 9 activation", allows a statement to be made as to whether a test substance is mutagenic in its original form or only after metabolism.
- the tobacco product proposed according to the invention points the traditional products have a greatly reduced risk potential on, because the natural substances used their antioxidations Properties on a variety of undesirable substances exercise and exert their effects at the place of metabolism.
- the Ames test was used to determine the mutagenic effect (loc. cit.) in the version "plate incorporation" as below described.
- test batches in petri dishes were evenly distributed on an agar which only allowed the growth of the his + back mutants.
- the petri dishes were subsequently incubated at 37 ° C in the dark for 48 hours. After the incubation period, the colonies formed from individual his + back-mutated bacteria were counted.
- the mutation frequency is the measure of the mutagenic activity.
- FIGS Some of the substances according to the invention with antimutagenic activity shown on smoke condensate.
- Scopoletin (7-hydroxy-6-methoxycoumarin) with a melting point of 205 ° C, without boiling point, is a natural plant ingredient in Virginia tobacco in a concentration of about Contain 300 ppm.
- scopoletin to detect the mainstream smoke, three versions of Trial cigarettes based on the same lot of cigarettes as prepared in Example 1.
- the concentration to scopoletin of tobacco by spraying on an ethanolic Solution of Scopoletin on the original cigarette tobacco Increased 330 ppm to 630 ppm and 5.330 ppm.
- the manufactured Cigarettes were smoked as described in Example 1, whereby the collected smoke condensate is dissolved in methanol has been.
- the filter sleeve design data corresponded to that of the example 1, the strand weight decreased to 930 ⁇ 20 mg, the amount of tobacco smoked was 785 mg.
- Cut tobacco with additions of cloves, cinnamon sticks and eugenol mixture Composition of the cut tobacco mixture Tobacco (% tr.) Cloves (% Tr.) Cinnamon sticks (% Tr.) added pure eugenol (% Tr.) 1 70 30th --- --- 2nd 70 --- 30th --- 3rd 70 15 15 --- 4th 94.9 --- --- 5.1 5 100 --- --- --- --- ---
- the experimental cigarettes were smoked under standard conditions (see example 1).
- the resulting smoke condensate solutions were examined with the Ames test according to Example 2, and in the embodiment "with S9 activation".
- the test results are shown graphically in FIG.
- the mutagenicity of the smoke condensate of mixture 1 was increased 55.5% of the effect of the comparison diminished, which corresponds to the explain the amount of eugenol contained in the cloves.
- the used Carnations had an eugenic content of 17.0%. In contrast this can be accompanied by the surprising reduction in mutagenicity of the smoke condensate of mixture 2 to 65.3% not alone with the amounts of cinnamaldehyde and eugenol contained.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Manufacture Of Tobacco Products (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Compounds Of Unknown Constitution (AREA)
Claims (19)
- Produit susceptible d'être fumé constitué par du tabac et/ou une autre matière susceptible d'être fumée, où le tabac et/ou la matière susceptible d'être fumée contient une addition de substances naturelles à effet antioxydant et/ou de produits de synthèse de celles-ci analogues aux substances naturelles, caractérisé en ce que l'addition est une combinaison(a) de vitamines à effet antioxydant, choisies dans le groupe consistant en le rétinol, l'α-tocophérol, leurs précurseurs et/ou leurs dérivés, et(b) d'autres substances naturelles d'origine végétale à propriétés antimutagènes et aromatisantes choisies dans le groupe consistant en l'éthylvanilline, l'aldéhyde cinnamique, l'anisaldéhyde, l'eugénol, le limonène, la cannelle et l'extrait de cannelle.
- Produit susceptible d'être fumé selon la revendication 1, caractérisé en ce qu'il contient jusqu'à 25 % en masse de substances naturelles à effet antioxydant et/ou de produits de synthèse identiques aux substances naturelles.
- Produit susceptible d'être fumé selon la revendication 2, caractérisé en ce qu'il contient 1 à 5 % en masse de substances naturelles à effet antioxydant et/ou de produits de synthèse identiques aux substances naturelles.
- Produit susceptible d'être fumé selon l'une des revendications 1 à 3, caractérisé en ce qu'il s'agit d'une cigarette avec ou sans filtre.
- Produit susceptible d'être fumé selon l'une des revendications 1 à 3, caractérisé en ce qu'il s'agit d'un cigarillo avec ou sans filtre.
- Produit susceptible d'être fumé selon l'une des revendications 1 à 3, caractérisé en ce qu'il s'agit d'une cartouche de tabac avec ou sans filtre.
- Produit susceptible d'être fumé selon l'une des revendications 1 à 3, caractérisé en ce qu'il s'agit de tabac à fumer sous forme de scaferlati ou de tabac à pipe.
- Produit susceptible d'être fumé selon l'une des revendications 4 à 6, caractérisé en ce que le filtre contient jusqu'à 50 % en masse de substances naturelles à effet antioxydant et/ou de produits de synthèse identiques aux substances naturelles selon la revendication 1.
- Produit susceptible d'être fumé selon la revendication 8, caractérisé en ce que le filtre contient 1 à 20 % en masse de substances naturelles à effet antioxydant et/ou de produits de synthèse identiques aux substances naturelles selon la revendication 1.
- Produit susceptible d'être fumé selon la revendication 4, caractérisé en ce que le papier à cigarette contient jusqu'à 50 % en masse de substances naturelles à effet antioxydant et/ou de produits de synthèse identiques aux substances naturelles selon la revendication 1.
- Produit susceptible d'être fumé selon l'une des revendications précédentes, caractérisé en ce que la matière de base susceptible d'être fumée est constituée par des mélanges de tabacs en plaques ou de tabac en plaques et de tabac en feuilles.
- Produit susceptible d'être fumé selon l'une des revendications précédentes, caractérisé en ce que la matière susceptible d'être fumée contient jusqu'à 25 % en masse de substances naturelles à effet antioxydant et/ou de produits de synthèse identiques aux substances naturelles selon la revendication 1.
- Produit susceptible d'être fumé selon l'une des revendications précédentes, caractérisé en ce que la matière susceptible d'être fumée est un mélange sans tabac constitué par une matière végétale qui dérive du tussilage, de la menthe poivrée, de l'ortie, du grand plantain, de la menthe crêpue, de la lavande, du thym, de feuilles de guigne ou de griotte, de feuilles de renouée, de feuilles de roses, de feuilles de piment ou de l'écorce de cannelle.
- Produit susceptible d'être fumé selon la revendication 13, caractérisé en ce que la matière susceptible d'être fumée dérive de l'écorce de cannelle.
- Produit susceptible d'être fumé selon les revendications 11 à 14, caractérisé en ce que la matière susceptible d'être fumée est une combinaison d'un mélange de tabacs et d'un mélange sans tabac.
- Procédé de fabrication d'un produit susceptible d'être fumé selon les revendications 1 à 15 de manière connue en soi, dans lequel on incorpore ou avive les substances naturelles à effet antioxydant et/ou leurs produits de synthèse identiques aux substances naturelles d'une manière connue en soi dans le tabac et/ou dans une autre matière susceptible d'être fumée.
- Procédé selon la revendication 16, caractérisé en ce que la matière susceptible d'être fumée comprend un mélange sans tabac de matière végétale, de papiers d'enveloppe, de supports, de colle de jonction et analogues.
- Procédé selon les revendications 16 et 17, caractérisé en ce que le produit susceptible d'être fumé est une cigarette, un cigarillo ou une cartouche de tabac avec filtre, dans le filtre desquels on incorpore ou avive jusqu'à 50 % en masse de substances naturelles à effet antioxydant et/ou de produits de synthèse identiques aux substances naturelles selon la revendication 1.
- Procédé selon la revendication 18, caractérisé en ce que l'on remplace en partie ou totalement les substances utilisées habituellement comme durcisseur pour les fibres d'acétate de cellulose formant le filtre ultérieur par les substances naturelles à effet antioxydant selon la revendication 1 et/ou leurs produits de synthèse identiques aux substances naturelles.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI9530458T SI0756461T1 (en) | 1994-04-19 | 1995-04-18 | Tobacco products, or substances similar to such products, containing natural substances with anti-oxidant properties, and process for producing the same |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4416101A DE4416101C2 (de) | 1994-04-19 | 1994-04-19 | Tabakerzeugnisse oder Tabakerzeugnissen ähnliche Waren mit antioxidativ wirkenden Naturstoffen und Verfahren zur Herstellung derselben |
DE4416101 | 1994-04-19 | ||
PCT/EP1995/001452 WO1995028098A1 (fr) | 1994-04-19 | 1995-04-18 | Produits du tabac ou substances analogues contenant des substances naturelles a action antioxydante, et leur procede de production |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0756461A1 EP0756461A1 (fr) | 1997-02-05 |
EP0756461B1 true EP0756461B1 (fr) | 2000-11-02 |
Family
ID=6517522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95917934A Expired - Lifetime EP0756461B1 (fr) | 1994-04-19 | 1995-04-18 | Produits du tabac ou substances analogues contenant des substances naturelles a action antioxydante, et leur procede de production |
Country Status (27)
Country | Link |
---|---|
US (1) | US5944026A (fr) |
EP (1) | EP0756461B1 (fr) |
JP (1) | JPH10503082A (fr) |
KR (1) | KR100357665B1 (fr) |
CN (1) | CN1148324A (fr) |
AT (1) | ATE197226T1 (fr) |
BG (1) | BG63420B1 (fr) |
CA (1) | CA2184592A1 (fr) |
CZ (1) | CZ294496A3 (fr) |
DE (2) | DE4416101C2 (fr) |
DK (1) | DK0756461T3 (fr) |
EE (1) | EE9600149A (fr) |
ES (1) | ES2151598T3 (fr) |
GR (1) | GR3035240T3 (fr) |
HK (1) | HK1012873A1 (fr) |
HU (1) | HUT76247A (fr) |
LV (1) | LV11721B (fr) |
MD (1) | MD1976B2 (fr) |
PL (1) | PL177413B1 (fr) |
PT (1) | PT756461E (fr) |
RO (1) | RO117888B1 (fr) |
RU (1) | RU2142729C1 (fr) |
SI (1) | SI0756461T1 (fr) |
SK (1) | SK120496A3 (fr) |
TW (1) | TW272117B (fr) |
UA (1) | UA45336C2 (fr) |
WO (1) | WO1995028098A1 (fr) |
Families Citing this family (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4416101C2 (de) * | 1994-04-19 | 1997-06-12 | Reemtsma H F & Ph | Tabakerzeugnisse oder Tabakerzeugnissen ähnliche Waren mit antioxidativ wirkenden Naturstoffen und Verfahren zur Herstellung derselben |
DE19541873A1 (de) * | 1995-11-09 | 1997-05-15 | Rhodia Ag Rhone Poulenc | Filterzigarette |
JPH1192410A (ja) * | 1997-09-25 | 1999-04-06 | Naohiko Sato | 抗酸化活性物質 |
US6082370A (en) * | 1998-02-09 | 2000-07-04 | Rousseau Research, Inc. | Cigarette with dry powered Vitamin E |
EA002711B1 (ru) * | 1998-02-09 | 2002-08-29 | Руссо Рисеч, Инк. | Табачные изделия с витамином е |
US6615842B1 (en) | 1998-02-13 | 2003-09-09 | Cerami Consulting Corp. | Methods for removing nucleophilic toxins from tobacco smoke |
EE200100445A (et) * | 1999-02-26 | 2002-12-16 | H.F. & Ph.F. Reemtsma Gmbh | Suitsetatav toode |
DK1309253T3 (da) * | 2000-06-26 | 2007-09-17 | Glycanex B V | Fremgangsmåder og indretninger til fjernelse af nukleofile toksiner fra tobak og tobaksrög |
US20050138910A1 (en) * | 2000-10-16 | 2005-06-30 | Peter Rohdewald | Air filter with scavenging effect on free radicals in gaseous phase and its method of preparation |
US7325548B2 (en) * | 2001-04-09 | 2008-02-05 | George Frederick Enslin | Smoker's requisite |
KR20030004562A (ko) * | 2001-07-05 | 2003-01-15 | 정진남 | 담배 |
US6953040B2 (en) * | 2001-09-28 | 2005-10-11 | U.S. Smokeless Tobacco Company | Tobacco mint plant material product |
HUP0201257A2 (hu) * | 2002-04-17 | 2004-05-28 | Péter Rozim | Szűrőbetét füstszűrős cigarettához |
US20040255965A1 (en) * | 2003-06-17 | 2004-12-23 | R. J. Reynolds Tobacco Company | Reconstituted tobaccos containing additive materials |
BRPI0415682A (pt) * | 2003-11-03 | 2006-12-19 | Us Smokeless Tobacco Co | tabaco sem fumaça aromatizado e métodos de fabricação |
EP1862084B1 (fr) | 2005-03-02 | 2013-01-16 | Japan Tobacco, Inc. | Appareil de production de cigarettes |
EP1903897B1 (fr) * | 2005-07-08 | 2009-10-21 | Ioto International Indústria e Comércio de Produtos aromáticos Ltda | Appareil de reconstitution de poudres d'origine vegetale |
US20070207989A1 (en) * | 2006-03-03 | 2007-09-06 | Savipu Pharmaceuticals | Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases |
US7795306B2 (en) * | 2006-03-03 | 2010-09-14 | Inderjit Kumar Dev | Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of NF-κB |
US7323476B2 (en) * | 2006-03-03 | 2008-01-29 | Savipu Pharmaceuticals | Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases |
US20070243273A1 (en) * | 2006-04-12 | 2007-10-18 | Savipu Pharmaceuticals | Reduction of the Deleterious Effects of Tobacco Smoking |
US20080017207A1 (en) * | 2006-07-18 | 2008-01-24 | Savipu Pharmaceuticals | Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2 |
US20080187608A1 (en) * | 2007-02-05 | 2008-08-07 | Savipu Pharmaceuticals | Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases |
US20090022821A1 (en) * | 2007-07-17 | 2009-01-22 | Inderjit Kumar Dev | Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseases |
KR100903951B1 (ko) | 2007-07-19 | 2009-06-25 | 주식회사 케이티앤지 | 주류연 중 자유 라디칼 제거용 아스코르빈산 유도체 함유궐련 필터 |
US8360072B2 (en) | 2009-10-09 | 2013-01-29 | Philip Morris Usa Inc. | Combination treatment of tobacco extract using antioxidants and antioxidant scavengers |
CN102495162B (zh) * | 2011-11-16 | 2013-11-20 | 中国烟草总公司郑州烟草研究院 | 一种配方烟丝中丁子香酚含量的测定方法 |
CN102499437A (zh) * | 2011-11-20 | 2012-06-20 | 红云红河烟草(集团)有限责任公司 | 一种掺配薰衣草的烟草烘烤调香方法 |
KR101475611B1 (ko) * | 2013-07-01 | 2014-12-22 | 이규서 | 방향요법을 이용한 항 스트레스 담배의 제조방법 |
CN103601710B (zh) * | 2013-11-04 | 2015-12-02 | 广东中烟工业有限责任公司 | 香豆素衍生物及其制备方法和应用 |
MX2016016298A (es) * | 2014-06-19 | 2017-05-01 | Daicel Corp | Banda de fibra de filtro de cigarrillo. |
RU2593086C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593076C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2583778C1 (ru) * | 2015-03-27 | 2016-05-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593082C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593084C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593071C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593074C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593070C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2586472C1 (ru) * | 2015-03-27 | 2016-06-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593085C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2586477C1 (ru) * | 2015-03-27 | 2016-06-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593081C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593072C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2584868C1 (ru) * | 2015-03-27 | 2016-05-20 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593083C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2586478C1 (ru) * | 2015-03-27 | 2016-06-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593075C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593073C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593068C1 (ru) * | 2015-03-27 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2586474C1 (ru) * | 2015-03-27 | 2016-06-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2594138C1 (ru) * | 2015-04-10 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593078C1 (ru) * | 2015-04-10 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной смеси для кальяна |
RU2584856C1 (ru) * | 2015-04-10 | 2016-05-20 | Олег Иванович Квасенков | Способ производства курительной смеси для кальяна |
RU2593118C1 (ru) * | 2015-04-10 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593077C1 (ru) * | 2015-04-10 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной смеси для кальяна |
RU2594139C1 (ru) * | 2015-04-10 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593116C1 (ru) * | 2015-04-10 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2594140C1 (ru) * | 2015-04-10 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2586475C1 (ru) * | 2015-04-10 | 2016-06-10 | Олег Иванович Квасенков | Способ производства курительной смеси для кальяна |
RU2593134C1 (ru) * | 2015-04-10 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2596101C1 (ru) * | 2015-04-10 | 2016-08-27 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" | Способ выработки курительной композиции для кальяна |
RU2594141C1 (ru) * | 2015-04-10 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593977C1 (ru) * | 2015-04-10 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593119C1 (ru) * | 2015-04-20 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593130C1 (ru) * | 2015-04-20 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593126C1 (ru) * | 2015-04-20 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593128C1 (ru) * | 2015-04-20 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593120C1 (ru) * | 2015-04-20 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2594132C1 (ru) * | 2015-04-20 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2594133C1 (ru) * | 2015-04-20 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593978C1 (ru) * | 2015-04-20 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2594135C1 (ru) * | 2015-04-28 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2594137C1 (ru) * | 2015-04-28 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2594134C1 (ru) * | 2015-04-28 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593969C1 (ru) * | 2015-04-28 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593123C1 (ru) * | 2015-04-28 | 2016-07-27 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2594136C1 (ru) * | 2015-04-28 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2593974C1 (ru) * | 2015-05-20 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2596446C1 (ru) * | 2015-05-20 | 2016-09-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
RU2599356C1 (ru) * | 2015-05-20 | 2016-10-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" | Способ производства курительной композиции для кальяна |
RU2593976C1 (ru) * | 2015-05-20 | 2016-08-10 | Олег Иванович Квасенков | Способ производства курительной композиции для кальяна |
CN105394808A (zh) * | 2015-12-17 | 2016-03-16 | 立场电子科技发展(上海)有限公司 | 一种电子烟雾化液 |
US20190192449A1 (en) * | 2016-08-31 | 2019-06-27 | Richard Baybutt | Composition and use thereof |
WO2018158774A1 (fr) * | 2017-03-02 | 2018-09-07 | Marifuana Ltd | Produits en papier aromatisés et parfumés |
CN107485052A (zh) * | 2017-08-09 | 2017-12-19 | 江西中烟工业有限责任公司 | 一种脂溶性维生素在烟草嘴棒中的应用 |
SG10201903923SA (en) * | 2018-12-31 | 2020-03-30 | Ysq Int Pte Ltd | Apparatus and method for producing a filter element |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3339558A (en) * | 1966-10-28 | 1967-09-05 | Haskett Barry F | Smoking article and filter therefor containing vitamin a |
US3861401A (en) * | 1973-03-08 | 1975-01-21 | Theodore S Briskin | Smokable tobacco substitute material and method |
US3943943A (en) * | 1974-07-09 | 1976-03-16 | Liggett & Myers Incorporated | Cinnamic derivatives as tobacco additives |
US3940499A (en) * | 1974-09-19 | 1976-02-24 | International Flavors & Fragrances Inc. | Food or flavor containing 2,6,6-trimethyl-1-cyclohexen-1-ylacetaldehyde |
US4170236A (en) * | 1977-06-16 | 1979-10-09 | International Flavors & Fragrances Inc. | Isobutyl substituted heterocyclic compounds and uses for augmenting or enhancing the organoleptic properties of smoking compositions |
DE3200305C2 (de) * | 1982-01-08 | 1983-11-17 | B.A.T. Cigaretten-Fabriken Gmbh, 2000 Hamburg | Verfahren zur Verbesserung der Füllfähigkeit von Tabak, insbesondere Tabakblattschnitt |
US4516590A (en) * | 1982-11-26 | 1985-05-14 | Philip Morris Incorporated | Air-cured bright tobacco filler, blends and smoking articles |
CH662042A5 (en) * | 1983-07-14 | 1987-09-15 | Baumgartner Papiers Sa | Cigarette endpiece |
HU192213B (en) * | 1985-04-29 | 1987-05-28 | Pecsi Dohanygyar | Method for producing smoke filter neutralizing the materials injurious the health being in tobacco smoke particularly aldehydes |
JPS6214772A (ja) * | 1985-07-10 | 1987-01-23 | 中島 三夫 | 無害巻きたばこ |
US4727058A (en) * | 1985-09-26 | 1988-02-23 | International Flavors & Fragrances Inc. | Process for preparing natural benzaldehyde and acetaldehyde, natural benzaldehyde and acetaldehyde compositions, products produced thereby and organoleptic utilities therefor |
IT8717404A0 (it) * | 1987-05-07 | 1987-05-07 | Barbaro Daniele | Sistema di erogazione locale,per fumatori,della vitamina a (o di altri retinoidi) avente come eluente (solvente e veicolo) il fumo di sigaretta o di sigaro. |
WO1989001301A1 (fr) * | 1987-08-13 | 1989-02-23 | C.A. Blockers, Inc. | Article permettant de fumer du tabac |
US5000198A (en) * | 1989-06-13 | 1991-03-19 | Mituo Nakajima | Agent for removing noxious tobacco components |
JPH03219860A (ja) * | 1990-01-25 | 1991-09-27 | Daicel Chem Ind Ltd | たばこ煙用フィルター |
JPH0523159A (ja) * | 1991-07-19 | 1993-02-02 | Kikkoman Corp | タバコフイルター |
US5308874A (en) * | 1992-06-26 | 1994-05-03 | Vyrex Corporation | Airborne protectants against oxidative tissue damage |
JPH0662824A (ja) * | 1992-08-12 | 1994-03-08 | Kyodo Nyugyo Kk | タバコ煙からのフリ−ラジカルの除去法 |
DE4244467C2 (de) * | 1992-12-24 | 1996-11-14 | Reemtsma H F & Ph | Cigarette |
DE4416101C2 (de) * | 1994-04-19 | 1997-06-12 | Reemtsma H F & Ph | Tabakerzeugnisse oder Tabakerzeugnissen ähnliche Waren mit antioxidativ wirkenden Naturstoffen und Verfahren zur Herstellung derselben |
-
1994
- 1994-04-19 DE DE4416101A patent/DE4416101C2/de not_active Revoked
-
1995
- 1995-04-18 TW TW084103810A patent/TW272117B/zh active
- 1995-04-18 JP JP7526734A patent/JPH10503082A/ja active Pending
- 1995-04-18 MD MD96-0320A patent/MD1976B2/ro unknown
- 1995-04-18 HU HU9602896A patent/HUT76247A/hu unknown
- 1995-04-18 PT PT95917934T patent/PT756461E/pt unknown
- 1995-04-18 CN CN95192648A patent/CN1148324A/zh active Pending
- 1995-04-18 SK SK1204-96A patent/SK120496A3/sk unknown
- 1995-04-18 EE EE9600149A patent/EE9600149A/xx unknown
- 1995-04-18 RO RO96-01987A patent/RO117888B1/ro unknown
- 1995-04-18 UA UA96103945A patent/UA45336C2/uk unknown
- 1995-04-18 US US08/727,411 patent/US5944026A/en not_active Expired - Fee Related
- 1995-04-18 CA CA002184592A patent/CA2184592A1/fr not_active Abandoned
- 1995-04-18 AT AT95917934T patent/ATE197226T1/de not_active IP Right Cessation
- 1995-04-18 KR KR1019960705290A patent/KR100357665B1/ko not_active IP Right Cessation
- 1995-04-18 SI SI9530458T patent/SI0756461T1/xx unknown
- 1995-04-18 CZ CZ962944A patent/CZ294496A3/cs unknown
- 1995-04-18 DE DE59508825T patent/DE59508825D1/de not_active Expired - Fee Related
- 1995-04-18 DK DK95917934T patent/DK0756461T3/da active
- 1995-04-18 EP EP95917934A patent/EP0756461B1/fr not_active Expired - Lifetime
- 1995-04-18 WO PCT/EP1995/001452 patent/WO1995028098A1/fr not_active Application Discontinuation
- 1995-04-18 ES ES95917934T patent/ES2151598T3/es not_active Expired - Lifetime
- 1995-04-18 RU RU96121906A patent/RU2142729C1/ru active
- 1995-04-18 PL PL95316760A patent/PL177413B1/pl unknown
-
1996
- 1996-09-04 LV LVP-96-357A patent/LV11721B/lv unknown
- 1996-10-18 BG BG100927A patent/BG63420B1/bg unknown
-
1998
- 1998-12-21 HK HK98114162A patent/HK1012873A1/xx not_active IP Right Cessation
-
2001
- 2001-01-15 GR GR20010400056T patent/GR3035240T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RO117888B1 (ro) | 2002-09-30 |
TW272117B (fr) | 1996-03-11 |
SK120496A3 (en) | 1997-03-05 |
HK1012873A1 (en) | 1999-09-17 |
RU2142729C1 (ru) | 1999-12-20 |
CN1148324A (zh) | 1997-04-23 |
SI0756461T1 (en) | 2001-04-30 |
KR970701507A (ko) | 1997-04-12 |
DE59508825D1 (de) | 2000-12-07 |
HUT76247A (en) | 1997-07-28 |
ATE197226T1 (de) | 2000-11-15 |
UA45336C2 (uk) | 2002-04-15 |
DK0756461T3 (da) | 2000-12-18 |
ES2151598T3 (es) | 2001-01-01 |
WO1995028098A1 (fr) | 1995-10-26 |
DE4416101A1 (de) | 1995-10-26 |
PL316760A1 (en) | 1997-02-03 |
EP0756461A1 (fr) | 1997-02-05 |
LV11721B (en) | 1997-12-20 |
US5944026A (en) | 1999-08-31 |
HU9602896D0 (en) | 1996-12-30 |
KR100357665B1 (ko) | 2003-02-05 |
GR3035240T3 (en) | 2001-04-30 |
PL177413B1 (pl) | 1999-11-30 |
LV11721A (lv) | 1997-04-20 |
CA2184592A1 (fr) | 1995-10-26 |
BG63420B1 (bg) | 2002-01-31 |
CZ294496A3 (en) | 1997-04-16 |
MD1976B2 (ro) | 2002-08-31 |
PT756461E (pt) | 2001-04-30 |
EE9600149A (et) | 1997-04-15 |
BG100927A (en) | 1997-07-31 |
JPH10503082A (ja) | 1998-03-24 |
DE4416101C2 (de) | 1997-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0756461B1 (fr) | Produits du tabac ou substances analogues contenant des substances naturelles a action antioxydante, et leur procede de production | |
EP1843670B1 (fr) | Cigarette filtre | |
DE1517242A1 (de) | Filterelement | |
LV12123B (lv) | Cigarete ar filtru | |
DE69221635T2 (de) | Neue tabakersatzstoffe | |
EP0069056B1 (fr) | Procédé pour l'aromatisation de fumée de tabac ainsi que bout de cigarette pour mettre en oeuvre ce procédé et utilisation du procédé | |
DE3532618C2 (fr) | ||
DE2246221A1 (de) | Rauchmaterial, verfahren zu dessen herstellung und daraus hergestellte raucherzeugnisse | |
DE69830158T2 (de) | Regulierer für tabakraucharoma | |
EP1178741A2 (fr) | Produit que l'on peut fumer | |
DE533199C (de) | Verfahren zur Herstellung von Zigarettenpapier | |
LV11519B (en) | Ventilated filter cigarette | |
DE19746664A1 (de) | Dünne Cigarette | |
DE60034968T2 (de) | Verfahren und vorrichtung zum entfernen von nukleophilen toxinen aus tabak und tabakrauch | |
DD153571A5 (de) | Verfahren zur behandlung von rauchtabak zwecks schadstoffsenkung im rauch | |
DE1517320A1 (de) | Zusaetze fuer Tabakerzeugnisse | |
DE2738930A1 (de) | Rauchgegenstand | |
DE69202392T2 (de) | Verbesserungen betreffend Rauchartikel. | |
DE2256235A1 (de) | Verfahren zum behandeln von tabak | |
DE19957487A1 (de) | Rauchbare Artikel | |
DE2120913A1 (de) | Verfahren zur Herstellung von homogenisiertem Tabakmaterial | |
DE1517297C (de) | Rauchfilter fur Tabakwaren | |
DE2313996C3 (de) | Wasserlösliches, leicht resorbierbares Schnupfpulver und Verfahren zu seiner Herstellung | |
DE1517311C (de) | Verfahren zum Aromatisieren von Tabak mit Aromastoffen | |
DE1517306A1 (de) | Filter fuer Tabakerzeugnisse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19961025 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: LT PAYMENT 961025;SI PAYMENT 961025 |
|
17Q | First examination report despatched |
Effective date: 19970313 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: H.F. & PH.F. REEMTSMA GMBH |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: LT PAYMENT 19961025;SI PAYMENT 19961025 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20001102 |
|
REF | Corresponds to: |
Ref document number: 197226 Country of ref document: AT Date of ref document: 20001115 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: PATENTANWALTSBUREAU R. A. MASPOLI Ref country code: CH Ref legal event code: EP |
|
ITF | It: translation for a ep patent filed | ||
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20001102 |
|
REF | Corresponds to: |
Ref document number: 59508825 Country of ref document: DE Date of ref document: 20001207 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: GERMAN |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2151598 Country of ref document: ES Kind code of ref document: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20010202 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010418 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20010430 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20010122 |
|
PLBQ | Unpublished change to opponent data |
Free format text: ORIGINAL CODE: EPIDOS OPPO |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
26 | Opposition filed |
Opponent name: BRITISH AMERICAN TABACCO (GERMANY) GMBH Effective date: 20010712 |
|
PLBF | Reply of patent proprietor to notice(s) of opposition |
Free format text: ORIGINAL CODE: EPIDOS OBSO |
|
NLR1 | Nl: opposition has been filed with the epo |
Opponent name: BRITISH AMERICAN TABACCO (GERMANY) GMBH |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PLBF | Reply of patent proprietor to notice(s) of opposition |
Free format text: ORIGINAL CODE: EPIDOS OBSO |
|
PLBF | Reply of patent proprietor to notice(s) of opposition |
Free format text: ORIGINAL CODE: EPIDOS OBSO |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20020318 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20020321 Year of fee payment: 8 Ref country code: AT Payment date: 20020321 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20020325 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20020328 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20020405 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20020408 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20020409 Year of fee payment: 8 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: REEMTSMA CIGARETTENFABRIKEN GMBH |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20020426 Year of fee payment: 8 Ref country code: CH Payment date: 20020426 Year of fee payment: 8 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20020619 Year of fee payment: 8 |
|
NLT2 | Nl: modifications (of names), taken from the european patent patent bulletin |
Owner name: REEMTSMA CIGARETTENFABRIKEN GMBH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Free format text: H.F. & PH.F. REEMTSMA GMBH TRANSFER- REEMTSMA CIGARETTENFABRIKEN GMBH Ref country code: CH Ref legal event code: NV Representative=s name: BOVARD AG PATENTANWAELTE |
|
NLS | Nl: assignments of ep-patents |
Owner name: REEMTSMA CIGARETTENFABRIKEN GMBH |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CD |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: PC4A Free format text: REEMTSMA CIGARETTENFABRIKEN GMBH DE Effective date: 20020808 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030418 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030418 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030430 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030430 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030430 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030430 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
BERE | Be: lapsed |
Owner name: *REEMTSMA CIGARETTENFABRIKEN G.M.B.H. Effective date: 20030430 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031101 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031101 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031104 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20031101 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20030418 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
LTLA | Lt: lapse of european patent or patent extension |
Effective date: 20030418 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20031231 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20031031 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20030419 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20050418 |
|
PLAB | Opposition data, opponent's data or that of the opponent's representative modified |
Free format text: ORIGINAL CODE: 0009299OPPO |
|
R26 | Opposition filed (corrected) |
Opponent name: BRITISH AMERICAN TABACCO (GERMANY) GMBH Effective date: 20010712 |
|
PLBD | Termination of opposition procedure: decision despatched |
Free format text: ORIGINAL CODE: EPIDOSNOPC1 |
|
PLBM | Termination of opposition procedure: date of legal effect published |
Free format text: ORIGINAL CODE: 0009276 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: OPPOSITION PROCEDURE CLOSED |
|
27C | Opposition proceedings terminated |
Effective date: 20071126 |